Skip to Main Content

Paper Details

Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials.
Pract Radiat Oncol
0
2024
Author NameAffiliation
Andrew WarnerWestern University and London Regional Cancer Program
Glenn BaumanWestern University and London Regional Cancer Program
  • 1 - 2

Datasets

Release 1.2